Randomized Comparison of a Polymer-Free Sirolimus-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent in Patients With Diabetes Mellitus

Steffen Desch,Denis Schloma,Sven Möbius-Winkler,Sandra Erbs,Stephan Gielen,Axel Linke,Jiangtao Yu,Bernward Lauer,Klaus Kleinertz,Wilfried Dänschel,Gerhard Schuler,Holger Thiele

JACC: Cardiovascular Interventions（2011）

引用 38|浏览41

暂无评分

摘要

Conclusions Compared with the Taxus Liberté stent, the polymer-free sirolimus-eluting Yukon Choice stent failed to show noninferiority with regard to the primary endpoint, in-stent late lumen loss, in patients with diabetes mellitus after 9-month follow-up. Both stents showed comparable clinical efficacy and safety. (Yukon Choice Versus Taxus Liberté in Diabetes Mellitus; NCT00368953 )

查看译文

关键词

diabetes mellitus,late lumen loss,paclitaxel,sirolimus,stents

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要